Upload
others
View
5
Download
0
Embed Size (px)
Citation preview
- WHITE PAPER -
Regenerative medicine changes the world
Table of contents
2
■RBC project …3
■Regenerative medicine using stem cells …4
■Types and characteristics of stem cells …5
■"Stem cell regeneration treatment" and target diseases …6
■Medical Corporation Yushikai …7
■Number of diabetics in the world …8
■Improvement cases of "diabetes” & "liver dysfunction" …9
■Purpose of ICO …10
■ Token sale outline …11
■Token allocation & Use of funds …12
■Details of RBC Project …13
■Organization chart of RBC Project …14
■Roadmap …15
■About ICO & Potential risk …16
Our company is a bio venture company that agrees with the idea of the
Japan Regeneration Medicine Association(JRMA) and has a tie-up
relationship.
In Japan's regenerative medicine, according to legitimate procedures, we
are starting to provide stem cell therapy in various medical institutions
including the Yusikai, a member of the Japanese Society for Regenerative
Medicine.
In addition to diabetes and liver dysfunction, treatment was performed on
immunological diseases, and results such as partial remission (symptomatic
improvement state), complete remission (symptoms disappeared and
examination numerical values also indicate normal), and results such as
progress stop has been obtained, and it has proved to be highly effective.
This result shows that we can spread the stem cell therapy in earnest and
hope that many patients will receive treatment for diseases that have been
difficult to treat until now. At the same time, development of stem cell
treatment technology will be further advanced using AI technology. In
addition, we will promote the development of new drugs to obtain approval
for medicines.
This time, we will spread cutting-edge stem cell therapy technology to the
world and conduct ICO to become a new standard of medical care.
By using the RBC project to optimize treatment costs, we also use block
chain technology to protect customer information with a high security
level, and connect medical institutions offering stem cell therapy to patients
who wish to treat this treatment.
It is a project that combines cutting-edge stem cell therapy and cutting-
edge block-chain technology.
RBC project
3
Regenerative medicine using stem cells
The human body consists of about 60
trillion cells, and each cell has a role
determined by the function of the body
such as muscles and nerves. However,
there are special cells that do not have a
definite role and can change into various
cells.
It is "stem cells". "Stem cells" have the
ability to repair or regenerate cells and
tissues that have become unable to perform
their intended function by disease.
"Stem cell regeneration treatment" aims at
improving the condition by extracting
"stem cells" from adipocytes collected
from patients, culturing them and
administering them again to patients.
"Stem cells" extracted from own fat,
therefore, there is no possibility of
rejection is very reliable and highly safe
treatment methods.
In modern times medical care has advanced highly. However, on the other hand, lifestyle-related diseases such as diabetes, heart disease, stroke, hypertension,obesity and hyperlipemia continue to increase. These diseases were difficult to treat completely and the ' Symptomatic treatment ' was the main focus.
However, the future era is not going to cure after getting sick, but "prevention
medicine" which prevents in advance and makes a healthy life expectancy is
changing to the center world.
This RBC project is a cutting-edge treatment in the field of "stem cell
regeneration therapy".
Now, regenerative medicine is the most noteworthy field in the medical industry,
and continues to advance and develop rapidly, and new results around the world
are picked up every day.
Regenerative medicine is a way of treating cells and tissues and will open up a
new path to treatment for diseases that have been difficult to treat until now.
4
Types and characteristics of stem cells
Fertilized egg
Totipotent stem cell The ability to produce any kind of cell is called
"omnipotence", and having this ability is the "source of life"
that can be all cells, such as fetus and placenta, with only
about two weeks 'fertilized eggs' from right after
fertilization.
Embryonic Stem cell; Stem
cells within the early embryo
of fertilized ovum. It is
possible to become all cells,
research progress, but
practical application is
difficult from the ethical
problem. It is not carried out
to a person. ES cells (embryonic stem cells)
Pluripotent stem cells
iPS cells
Induced pluripotent stem cells induced Pluripotent Stem cell;
It is currently in the process of
being studied and has not been
carried out to people.
Somatic stem cells
Mesenchymal stem cells
Chondrocytes, tenocytes, osteoblasts,
muscle cells, cardiomyocytes,
hepatocytes, adipocytes,
glial cells, nerve cells,
fibroblasts,
vascular endothelial cells, etc.
Self-derived and highly safe (medical technology provided in this project)
Glial cells
Nerve cell
Neural stem cells Hematopoietic stem cells
Erythrocyte
White blood cell
platelet
Vascular endothelial stem cells
Vascular
endothelial cells
Hepatic stem cells
Hepatocytes
Epithelial system stem cells
Skin
Mucosal
epithelium
Somatic stem cells are stem cells that exist in many parts of our body. It is thought that there is
no ability to differentiate because the role is fixed, but it is known that "mesenchymal stem cells"
in the bone marrow have "differentiation ability" to become various cells. In a more recent study,
"fat-derived mesenchymal stem cells" It has been revealed that it has "differentiation ability."
Since adipose origin is easy to collect and abundant in quantity, it is being rapidly put into
practical use as a medical technology that can be utilized for realistic stem cell regeneration
treatment. Many clinical prescriptions for people are also being implemented.
5
In the relationship between aging and stem cells, when the neonate is taken as 1, in
the 80s, the number of tissue stem cells in the bone marrow has decreased to 1/200
of the newborn, that is, the decrease in stem cells has been found to be a cause of
aging .
"Stem cell regeneration treatment" is
to improve the disease condition by
increasing the number of stem cells
in the body by extracting "stem
cells" from adipocytes collected
from patients, culturing them and
administering them to the patient
himself again .
Immune disease
atopic
Atopic dermatitis
Alcohol urticaria
Allergic constitution
Sjogren's syndrome
Chemical hypersensitivity
Brain / neurological
diseases
Ethambutol visual neurosis
Facial paralysis
Cluster headache
Autonomic imbalance
Nerve sequelae
Hearing loss
Disc herniation
Epilepsy
Brainstem bleeding
Brain stem bleeding
sequelae
cerebral infarction
Cerebral infarction
sequelae
cerebral hemorrhage
Brain tumor
Tinnitus
Spinal stenosis
Metabolic disease
Diabetes
High fat thrombus
Renal dysfunction
Kidney disease
ventilation
Chronic renal failure
Neurodegenerative disease
ALS
Alzheimer's disease
Cerebral palsy
Parkinson's disease
Chronic axilloscopy
neuropathy
Respiratory disease
COPD
Bronchiectasis
asthma
Pulmonary suppuration
Exercise system / trauma
Tough damaging
Muscle
Lumbar spondylosis
Low back pain
Cervical spinal canal
stenosis
Tuberculous spinal caries
Malignant tumor
Malignant lymphoma
Stomach cancer
Liver cancer
Pleural mesothelioma
Esophageal cancer
Prostate cancer
Colon cancer
After ovarian cancer
surgery
Other
Menopause
sarcoidosis
Postpartum depression
Periodontal disease
Pressure sores
Prostatic hypertrophy
Male menopause
Wrist joint pain
Graves' disease
Behcet's disease
Glaucoma
Gastrointestinal disease
Liver dysfunction
Liver disease
Liver dysfunction
Reflux esophagitis
Enteritis
Constipation
Chronic gall bladder
Abnormality of
confluence of
pancreatobiliary
Cardiovascular disease
Acute myocardial
infarction
Angina pectoris
Hypertension
arrhythmia
Atrial septal defect
Idiopathic atrial
fibrillation
6
"Stem cell regeneration
treatment" and target diseases
Medical Corporation Yushikai
http://www.hellodc.net/pdf/hello_pdf01.pdf
Chief Director Yasushi:
Yasushi ChoMedical Corporation Yushikai
Wing Hello Dental / Medical Clinic
Treatment of diabetes using autologous adipose-derived stem cells
Plan number: PB7170014 (accepted)
Wing Hello Dental / Medical Clinic is an accredited medical institution that
officially obtains regenerative treatment of stem cells by acquiring the
provisional plan number of Type 2 Regenerative Medicine etc. for the
treatment of diabetes based on formal procedures to the Ministry of Health,
Labor and Welfare.
Yushikai is the world's first clinic in Japan that acquired a plan number from
the Ministry of Health, Labor and Welfare for regenerative medicine for the
treatment of diabetes.
7
This data summarizes the World Diabetes Union (IDF).
From the IDF data, the world suffers from diabetes at a rate of one out of
eleven people.
Diabetic patients are estimated to be 425 million in 2017, and 700 million
in 30 years.
Number of diabetics in the world
Country/Territory People with diabetes
China 114394.82
India 72946.39
United States of America 30187.48
Brazil 12465.83
Mexico 12030.06
Indonesia 10276.12
Russian Federation 8455.3
Egypt 8222.64
Germany 7476.8
Pakistan 7474.03
Japan 7234.23
Bangladesh 6926.26
Turkey 6694.46
Iran (Islamic Republic of) 4985.53
Thailand 4208.59
Saudi Arabia 3851.99
Philippines 3721.91
Spain 3584.53
Viet Nam 3535.69
http://www.diabetesatlas.org/
1st place China about 114 million people2nd place India about 73 million people3rd place Americans about 30 million people4th place Brazil about 12.5 million people5th place Mexico about 12 million people6th place Indonesia about 10 million people
In the top six places, three countries are located in Asia, and the number of people in the world is close to half a billion of diabetics.We aim to enhance the clinic and the culture facilities which are able to receive treatment for the patient in the world suffering from the diabetic which is considered to be an incurable disease in this way.
8
9
Improved cases of "diabetes & "liver dysfunction”
Currency code RBC
Purpose of ICO
All funds raised are for the development of the RBC project.
1.Enriching domestic / overseas clinics and culture facilities
2.Developing your own wallet
3.Optimize cost of stem cell therapy by expanding business
4.Pharmacy of stem cell therapy
5.Client support using block chain technology and optimization of stem cell
therapy using AI
6.Construction of a platform that can purchase health foods and cosmetics
7.Development of health management application and wearable terminal
10
Token name Rebirth Coin
Currency code RBC
Number issued 120,000 RBC
Type ERC20
Token Sales Price 1BTC=25RBC
1ETH=1RBC
Maximum number of tokens sold 60,000 RBC
※1RBC = about $300
Token sale outline
Phase1 2018
10/1~10/20
Distribution of
tokens
December 2018
20%Bonus
Phase2 2018
10/21~11/10
10%Bonus
Phase3 2018
11/11~11/30
5%Bonus
For example, if you buy 1 RBCs on October 1, you will get 0.2 RBCs for 20%, so you own a
total of 1.2 RBCs.
* Token sale out issuance limit Upper limit of 60,000 RBC is sold out, the token sale will end at
that point.
* The contents of the schedule may change depending on the progress of the project.
* Bonus content will be held for 6 months after distribution.
* For team reservations, we will lock you for one year after the sale ends.
* We will lock you for one year after using RBC.
Payment is accepted as Bitcoin / Ethereum. These are virtual currencies that are
circulated globally. We will change the legal currency once to these currencies and
purchase RBC.
The total number of issued RBCs shall be 120,000 RBC, and the maximum number
of issuance of selling at the time of token sale shall be 60,000.
Only if it does not reach the expected amount of funds procurement, it shall incinerate
(burn) the market distribution minute token for the unachieved amount of
procurement and then incinerate (burn) the same token from the team's holding.
For that reason, the market distribution token quantity and the team / development
token quantity are the same value and the balance is kept without being biased.
Also, during the token sale the following time bonus (distribution of tokens as a
predecessor privilege) will be applied.
Treatment cost 2% discountAdministration under 3,000 times
Treatment cost 3% discountAdministration over 3,000 times
Treatment cost 4% discountAdministration over 4,000 times
Over 1 RBC holders benefits
Treatment cost 5% discountAdministration over 5,000 times
Treatment cost 6% discountAdministration over 6,000 times
Treatment cost 7% discountAdministration over 7,000 times
Treatment cost 8% discountAdministration over 8,000 times
Treatment cost 9% discountAdministration over 9,000 times
Treatment cost 10% discountAdministration over 10,000 times
11
35%
30%
20%
10%
5%Expansion and research ofhospital facilities
System development
Marketing
Legal compliance
Management cost
12
Token allocation & Use of funds
50%
15%
35%Token sale
Token bonus
Team ownership
Token Sales Participants can distribute up to 50% of the number of copies issued.
This treatment can be expected to have a variety of effects, including anti-aging and diabetes.
Although stem cell therapy is currently attracting worldwide attention, it is the only five
countries in the world that can perform stem cell therapy in the United States,
Germany ,Switzerland, Russia (government agencies) and Japan.
In particular, as the demand for stem cell therapy rises in Asia, there are only Japan to be
accepted in neighboring countries. Companies and organizations that introduce Chinese
patients to overseas hospitals are born. The Japan has many benefits, such as being able to
access a medical residency visa from China.
In partnership with Chinese Travel Companies
Stem Cell Therapy's inbound service to Japan, centering on the Yushikai,
which is the only clinic in Japan that can perform regenerative medicine for
the purpose of diabetes treatment, starts.
As a saucer for this inbound service, we plan to install new culture facilities and
medical facilities, and we can expect the inflow of funds to regenerative medicine
on a global scale by using the RBC settlement by our own wallet.
Details of RBC Project
13
・Optimization of the cost of stem cell therapy
・Pharmaceutical treatment of stem cells
・Build a platform to purchase health food and cosmetics
・Development of health management application and wearable terminal
・Optimization of stem cell therapy using block chain technology, client support and AI
Based on the user's own
medical data, we propose a
supplement, household medical
equipment, cosmetics, health
food, and food materials to the
user, using big data such as diet
and exercise that are
accumulated on a daily basis.
Wearable devices visualize
your health and keep your
health data safe on the block
chain.
The daily health data will help
you manage your own health
and treat you at this project
partner clinic.
By using block chain technology,
we prevent leakage of client
information and enhance support
after treatment.
In addition, we aim to establish
the best stem cell therapy for the
symptoms by using AI
technology for the accumulation
of data by many treatments.
Stem cell therapy is a new
treatment that can be expected
to be effective for a variety of
symptoms. However, one-time
treatment is a high-millions-
tens treatment. Therefore, it is
the present situation that the
person who can receive this
treatment is limited
By conducting research and
clinical studies of therapeutic
formulations utilizing stem
cells and distributing them, we
aim to "optimize the cost of
stem cell therapy and become
a pharmaceutical".
The project aims to deliver the
regenerative medicine to many
people, to achieve the optimal
cost of treatment.
Organization chart of RBC project
14
Medical Corporation Yushikai
Tokyo Clinic Opening Schedule
Travel package for stem cell
therapy by
Chinese Travel Companese
Opening of Macau S.A.R. Clinic
Diabetes Regenerative Medicine Institute
Japan Regeneration Medicine Association
Roadmap
2018 2019 2020 2021 2022 2023 2024 2025
-PC CSS
Development
(Note 1)
-Development of
EC site platform
-Development and
implementation of
health promotion
applications
-Stabilization of the
management of medical
institutions
- Partnering with stem cell
clinics for beauty
- Partnering with stem cell
clinics for immune diseases
- Partnering with stem cell
clinics for skin diseases
- Spread of payment system
- Development of original
Wallet
-Development of
Japan and Asian city
Clinic
-Increase in culture
facilities
-EC Site
Platform
implementation
-Wearable
development
-Wearable
implementation
-CSS
Implementation
(Note1) PC:Private Chain
CSS:Client Support System
15
About ICO & Potential risks
Risk of losing access to this token due to loss of private key
Regulatory risksRisk by force
majeure
The private key is required to receive this token stored in the purchaser's digital wallet.Thus, loss of the private key of the digital wallet in which the purchaser's token is stored may result in loss of this token.
It is not always possible to predict how each regulatory authority will apply or apply the current regulations for the technology and use of this token.If regulatory or legal changes are illegal to operate in that jurisdiction, the law may cease to operate in that jurisdiction.
ICO and our success are influenced by a number of factors. As a result, the value of the RBC may fluctuate. The reasons may be affected by circumstances such as economic conditions, virtual currency token market conditions, political circumstances, war, natural disasters, or other unforeseen situations.
16
ICO (Initial Coin offering) is a technique for raising money by issuing and selling your own digital tokens.It is not a form of equity transfer, as in stock procurement, but as well as a purchase-type crowdfunding, which simply sells tokens.This token is not recognized as a "virtual currency" at the time of sale.In other words, ICO is not a "fund-raising" method, but rather a "token sales method" on a strict definition, and the purchaser of the token is not the "investor" who invests in the project. At the present time, the RBC token is not intended to be used as a payment of consideration to unspecified persons, and the exchange market with legal currency, bitcoin and other existing cryptographic currencies is not present.The above definition is also considered to be true for this ICO project.
What is ICO?
Although ICO's funding was only 36 million in the first quarter of 2017, in the second quarter, ICO's funding for the block chain was 790 million (22 times the previous quarter). It became clear that VC's investment in this field was significantly above 230 million million.The procurement amount Top10 all issuers have raised more than 5 billion yen and are expected to be in further growth markets in the future.The market capitalization of the entire virtual currency is surged this year in parallel with the growth rate of ico, and topped 170 billion dollars.Mount Gox has also overcome barriers such as embezzlement and closure of the Chinese exchange, and is actively trading today.
About ICO Market
The Plaza Commercial Centre Level 8, Suite 5,
Bisazza Street Sliema SLM1640, Malta
Reblo Co.,Ltd.